ROSEVILLE, Minn., June 1, 2017 /PRNewswire/ -- Rebiotix Inc., a clinical-stage microbiome company focused on harnessing the power of the human microbiome to treat challenging diseases, today announced ...
SAN DIEGO, June 5, 2017 /PRNewswire/ -- Zavante Therapeutics, Inc., a biopharmaceutical company focused on developing novel therapies to improve the outcomes of hospitalized patients, today announced ...
“Our presentations at ASM Microbe underscore our ongoing commitment to developing new anti-infectives to address the urgent need for innovation in this space,” said Jeffrey Stein, Ph.D., president and ...
This poster will be made available on the Company’s website on the “Publications: Posters & Presentations” page under the “Our Science” tab once the conference ends. About Iterum Therapeutics plc ...
Presentation Date and Location: June 16, 2023, 10:00AM – 5:00PM CT, Exhibit and Poster Hall (Hall BCD) Presentation Times: 10:30AM – 11:30AM CT and 4:00PM – 5:00PM CT ...
SAN DIEGO, May 30, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies ...
Poster: Session AAR-P-016 - AAR06 Friday Novel Approaches: Diagnostics/Discovery and Non-Traditional Therapies to Combat Drug-Resistant Infections; Poster Board Number: AAR-FRIDAY-459 Date and Time: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback